Medthority

How can we combat the myasthenic crisis? Listen to Tobias Ruck and Nils Erik Gilhus share their clinical experience of MG, with this compelling case study to help you identify early red flags and understand the importance of timely intervention #MedSky #NeuroSky

https://ow.ly/F9Tq50XkwHb

How are HRR mutations reshaping care pathways in mPC? Tune in to the first 5 episodes of our NEW podcast series to hear insights from host Alicia Morgans and guests on advances in HRR testing and the genetic landscape of mCRPC #MedSky #OncSky #ProstateCancer

ow.ly/FZLx50XkjTo

This #WorldStrokeDay, get the updates you need to know with our expert podcast series, Thrombosis in Conversation, hosted by @gbarnesmd.bsky.social. Stay ahead with highlights from #ESC2025, plus insights from Deborah Siegal on optimizing treatment duration #MedSky #CardioSky

ow.ly/hh0S50XjNC4

What is Nick James’ opinion on this ‘hotly debated topic’ in #prostatecancer care discussed at #ESMO25? We spoke to James about treatment options, improving access, and the future of AI-assisted healthcare, available to watch now on Medthority #MedSky #MedEd #OncSky

ow.ly/pyEs50Xj2p6

📰 It’s news-day Tuesday! Early #CIDP misdiagnosis remains common according to a recent multinational study, highlighting the need for improved diagnostic accuracy and more effective treatment strategies. Visit Medthority to find out more now #MedSky #MedEd #MedicalNews

ow.ly/lVYy50XiSuw

Get the latest insights from #DGHO2025 over on our YouTube channel! Watch Bernd Kasper discuss the most significant unmet needs and the importance of understanding the lived experience of people with desmoid tumors #MedSky #OncSky

ow.ly/e52g50XicbB

Heading to #ACR25 or just keeping up with the latest in #rheumatology? Check out Medthority for the opportunity to earn #CME credit with our new HLH/MAS masterclass from Fabrizio de Benedetti featuring insights on diagnosis and treatment strategies #MedSky
ow.ly/sNW750XgZJo

Short on time? Catch up on advances in AATD liver care relevant to your clinical practice from #EASL2025 with our NEW visual summary. For key points on detection and care pathways, plus emerging therapies at a glance, download our infographic today #MedSky #LiverSky

ow.ly/oAWW50XgYX5

Missed out on #ESMO25? Stay tuned for upcoming congress highlights that fit around your busy schedule. For now, catch up with the latest insights on improving the patient experience in #bladdercancer care from Joshua Meeks and Félix Guerrero-Ramos #MedSky #OncSky #NMIBC

ow.ly/e2oz50Xgh8b

👏 That’s the end of the webinar! Thank you to our excellent speakers for their insights. The key takeaways? AA disproportionately impacts SOC populations, and more research is needed to improve patient outcomes. For now, compassion and curiosity is key 🔑

#MedSky #DermSky #InclusiveDermatology

❓ An insightful Q&A session to round-off the webinar with questions on diagnostic uncertainty, existing gaps in research in SOC populations, and how clinical trials can be more inclusive

#MedSky #DermSky #InclusiveDermatology #AlopeciaAreata #HCPWebinar #CME

💬“Communication is key and our approach is everything” - Loren Krueger.

Krueger shares how to have conversations with SOC patients, including incorporating language that crosses cultures

#MedSky #DermSky #InclusiveDermatology #HCPWebinar #CME #AlopeciaAreata

🔄 Loren Krueger leads the discussion on holistic AA management, addressing psychosocial impacts and inclusive hair care to support the whole patient beyond clinical symptoms

#MedSky #DermSky #InclusiveDermatology #AlopeciaAreata #HCPWebinar #CME

📂 Using real-life cases, Chair Antonella Tosti shares culturally sensitive, personalized strategies for treating AA in SOC populations, emphasizing practical, patient-centered care and the importance of trichoscopy

#MedSky #DermSky #InclusiveDermatology #AlopeciaAreata #HCPWebinar #CME

🔎 Kristen Lo Sicco highlights tools for assessing AA severity, showing how dermoscopy and structured scoring can help address disparities in diagnosis and treatment for SOC patients.

Why is this important? We need to look beyond scalp hair loss!

#MedSky #DermSky #HCPWebinar #CME #AlopeciaAreata

Kristen Lo Sicco shares study data on AA in SOC patients:

📈 Increased prevalence of younger patients

👩🏾 Significant female predominance

➕ Many had more than one atopic condition

#MedSky #DermSky #InclusiveDermatology #AlopeciaAreata #HCPWebinar #CME

“You have to think about how hair fits into their lives and their lifestyles.”

Arash Mostaghimi urges us to approach patients with a sense of curiosity and compassion 🩷

#MedSky #DermSky #InclusiveDermatology #AlopeciaAreata #HCPWebinar #CME

🔑 Arash Mostaghimi shares key considerations:

➿ Curly hair can hide a lot of disease

❗ Range of mimickers is much higher, especially with chronic disease

#MedSky #DermSky #InclusiveDermatology #AlopeciaAreata #HCPWebinar #CME

📈 Arash Mostaghimi kicks us off with insights on the epidemiology of #alopeciaareata. The bottom line? Black and Asian patients have the highest rates of AA, but what does this mean for presentation?

#MedSky #DermSky #InclusiveDermatology #HCPWebinar #CME

📣Join us for LIVE coverage of our accredited webinar ‘Inclusive approaches: Addressing #alopeciaareata in #skinofcolor populations’, starting now! Chaired by Antonella Tosti, hear from Arash Mostaghimi, Kristen Lo Sicco, and Loren Krueger on the updates you need to know

#MedSky #DermSky #CME

Tune in today from 12pm EST/5pm BST for LIVE coverage of our accredited webinar, Inclusive approaches: Addressing #alopeciaareata in skin of color populations. Can’t attend? Click the link to register for the on-demand recording #MedSky #DermSky #CME

ow.ly/T7ql50XfyJh

📰 It’s news-day Tuesday! Catch up with the updates you need to know from #ESMO25 with articles by our expert scientific team. From #NSCLC to #NMIBC, scroll through our news page for the latest trial data and insights on a potential “new standard of care” #MedSky #OncSky

ow.ly/ssrv50XfpYg

EGFR-mutated NSCLC: Osimertinib data updates The latest from FLAURA2 and NorthStar presented at ESMO 2025 offers guidance on the use of osimertinib in EGFR-mutated NSCLC.

If you've enjoyed our real-time updates from #ESMO25, head over to Medthority to catch-up with our congress highlights and keep an eye out for expert interviews coming soon 👀

#MedSky #OncSky #LungCancer

ow.ly/aego50XeZIL

👏Great insights at our final session of #ESMO2025!

From ADCs to MTAP loss, this session spotlighted new strategies for #NSCLC beyond classic genomic targets.

Emerging biomarkers, synthetic lethality, and immune modulation are reshaping therapeutic possibilities

#MedSky #OncSky #LungCancer

🫁 MTAP loss in NSCLC leads to MTA accumulation and partial PRMT5 inhibition.

“This affects immune surveillance and may shape response to therapy.” - Keith Kerr at #ESMO25

#Oncology #OncSky #MedEd #MedSky #NSCLC #LungCancer

💬 “Transcription factors are tough to drug, but their need to bind coactivators creates vulnerabilities,” says Nicolas Thomä.

PROTACs exploit these to degrade key drivers in NSCLC

#ESMO25 #Oncology #OncSky #MedEd #MedSky #NSCLC #LungCancer

Lyudmila Bazhenova highlights how bispecific antibodies are ushering a new therapeutic modality in lung cancer. A new frontier in redirecting immune response 🔄

#ESMO25 #Oncology #OncSky #MedEd #MedSky #LungCancer #NSCLC

🧬 “ADCs show impressive activity in oncogene-driven NSCLC, especially EGFR-mutant cases.” - Federico Cappuzzo at #ESMO25.

Targeted cytotoxicity may offer new options beyond traditional chemo

#Oncology #OncSky #MedEd #MedSky #LungCancer #NSCLC

🫁 Join us for our final session round-up from #ESMO2025 on Innovative Approaches in NSCLC: Beyond AGA, chaired by Lyudmila Bazhenova & May-Lucie Meyer

Scroll through our thread for more on cutting-edge strategies like ADCs, bispecifics, PROTACs & DNA repair targeting

#ESMO25 #OncSky #MedSky

Don’t miss expert insights on NF1 management from #EANO2025 over on our YouTube channel! We caught up with Said Farschtschi to discuss clinical challenges across both pediatric and adult populations, and the current treatment landscape #MedSky #NeuroSky

ow.ly/84LP50XeLtW